UBS Upgrades GE HealthCare: $88 Price Target Planby Mark Eisenberg 12.02.2024UBS upgrades GE HealthCare Technologies to Neutral, raises price target to $88. Positive outlook for company's margin improvement and revenue ...
Trade Desk Inc: Revenue Concerns Prompt Sell Ratingby Mark Eisenberg 12.02.2024Benchmark analysts maintain their Sell rating for The Trade Desk Inc. due to revenue concerns and predict a possible stock ...
Uber Surpasses Profit Expectations in 14th Yearby Mark Eisenberg 12.02.2024Uber reports first annual profit in 14 years, beating analyst estimates. Gross bookings and total trips taken showed significant growth. ...
Gold and Silver Slide as Oil Prices Surgeby Lilu Anderson 12.02.2024Today's commodity market update highlights fluctuations across sectors, including declines in precious and industrial metals, mixed performance in energy commodities, ...
AN2 Therapeutics Pauses Trial: Efficacy Concerns Riseby Mark Eisenberg 12.02.2024AN2 Therapeutics voluntarily pauses enrollment in its epetraborole clinical trial due to lower efficacy. Safety is not a concern. The ...
Ethereum Gas Fees Surge Amid Transaction Volumeby John Darbie 12.02.2024Gas fees on the Ethereum network have soared to a multi-month high due to increased transaction volume, causing concern among ...
Apple’s AI-Driven iPhone Boost Spurs Stock Growthby Lilu Anderson 12.02.2024Analysts predict AI-integrated iPhones could boost Apple's stock and sales, potentially leading to more device replacements and revenue opportunities.
Loop Capital Downgrades FMC Corp.: Sell Now?by Mark Eisenberg 12.02.2024Loop Capital downgrades FMC Corp. to Hold and lowers price target due to inventory challenges in critical markets. Concerns over ...
Bond Yields Pause Amid Economic Concernsby Mark Eisenberg 12.02.2024Bond yields take a breather as the 10-year Treasury backs up. Rate strategists raise concerns while historical trends suggest gains ...
Denny’s Q4 Earnings: Analysts Predict Revenue Declineby Mark Eisenberg 12.02.2024Denny's is expected to report a decline in Q4 revenue, raising concerns among investors. Analysts have revised estimates downward, but ...